GAMOGEN INC
NT 10-K, 2000-05-30
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: COMVERSE TECHNOLOGY INC/NY/, 10-K405/A, 2000-05-30
Next: TOTAL RESEARCH CORP, 8-K, 2000-05-30



<PAGE>


                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 12b-25

                          NOTIFICATION OF LATE FILING

(Check One):  [X] Form 10-K      [ ] Form 20-F      [ ] Form 11-K
              [ ] Form 10-Q      [ ] Form N-SAR

For Period Ended:  ____________________

[  ]          Transition Report on Form 10-K
[  ]          Transition Report on Form 20-F
[  ]          Transition Report on Form 11-K
[  ]          Transition Report on Form 10-Q
[  ]          Transition Report on Form N-SAR

For the Transition Period Ended: ____________________________________


- -------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.
- -------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

- -------------------------------------------------------------------------------

PART I -- REGISTRANT INFORMATION

- -------------------------------------------------------------------------------
Full Name of Registrant

GAMOGEN, INC.
- -------------------------------------------------------------------------------
Former Name if Applicable


- -------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

1930 Village Center Circle, Suite 3-183
Summerlin, Nevada 89134-1389
- -------------------------------------------------------------------------------
City, State and Zip Code


PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)

         (a)  The reasons described in reasonable detail in Part III of this
              form could not be eliminated without unreasonable effort or
              expense;

[X]      (b)  The subject annual report, semi-annual report, transition report
              on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
              will be filed on or before the fifteenth calendar day following
              the prescribed due date; or the subject quarterly report of
              transition report on Form 10-Q, or portion thereof will be filed
              on or before the fifth calendar day following the prescribed due
              date; and

         (c)  The accountant's statement or other exhibit required by
              Rule 12b-25(c) has been attached if applicable.


PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. In connection with a changes of control of
registrant effected in November 1999, registrant disposed of substantially all
of its assets to its former parent, auditors and registrant's new management all
completely assessment of allocations relating to this disposition.


                                    Potential persons who are to respond to the
                                    collection of information contained in this
(Attach Extra Sheets if Needed)     form are not required to respond unless the
                                    form displays a currently valid OMB control
                                    number.


SEC 1344 (2-99)
<PAGE>

                             EXCHANGE ACT -- FORMS
                                                               1892     10-13-99

PART IV -- OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification


    AARON A. GRUNFELD                       702               615-5922
    ----------------------------------------------------------------------------
              (Name)                    (Area Code)     (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
    of 1940 during the preceding 12 months or for such shorter period that the
    registrant was required to file such report(s) been filed? If answer is
    no, identify report(s). [X] Yes [ ] No


- --------------------------------------------------------------------------------

(3) Is it anticipated that any significant change in results of operations from
    the corresponding period for the last fiscal year will be reflected by the
    earnings statements to be included in the subject report or portion thereof?

                                                    [X]  Yes     [ ]  No

    If so, attach an explanation of the anticipated change, both narratively and
    quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.



AS PREVIOUSLY REPORTED, REGISTRANT HAS DISPOSED OF SUBSTANTIALLY ALL ITS ASSETS.
- --------------------------------------------------------------------------------

                                  GAMOGEN INC.
- --------------------------------------------------------------------------------
               (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.



Date: 5/26/00                        By: /s/ AARON A. GRUNFELD
     ---------                           ---------------------------

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- -------------------------------------------------------------------------------
                                    ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
- -------------------------------------------------------------------------------

                              GENERAL INSTRUCTIONS

1.       This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
         Rules and Regulations under the Securities Exchange Act of 1934.

2.       One signed original and four conformed copies of this form and
         amendments thereto must be completed and filed with the Securities and
         Exchange Commission, Washington, D.C. 20549, in accordance with
         Rule 0-3 of the General Rules and Regulations under the Act. The
         information contained in or filed with the form will be made a matter
         of public record in the Commission files.

3.       A manually signed copy of the form and amendments thereto shall be
         filed with each national securities exchange on which any class of
         securities of the registrant is registered.

4.       Amendments to the notifications must also be filed on Form 12b-25 but
         need not restate information that has been correctly furnished. The
         form shall be clearly identified as an amended notification.

5.       Electronic Filers. This form shall not be used by electronic filers
         unable to timely file a report solely due to electronic difficulties.
         Filers unable to submit a report within the time period prescribed due
         to difficulties in electronic filing should comply with either Rule 201
         or Rule 202 or Regulation S-T (Section 232.201 or Section 232.202 of
         this chapter) or apply for an adjustment in filing date pursuant to
         Rule 13(b) of Regulation S-T (Section 232.13(b) of this chapter).


                                             AARON A. GRUNFELD



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission